These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 33341481)

  • 41. Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021).
    Panovska-Stavridis I; Ridova N; Stojanoska T; Demiri I; Stevanovic M; Stojanovska S; Ristevska T; Dimkovski A; Filipce V; Dimovski A; Grozdanova A
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Apr; 42(1):5-18. PubMed ID: 33894123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is hydroxychloroquine beneficial for COVID-19 patients?
    Li X; Wang Y; Agostinis P; Rabson A; Melino G; Carafoli E; Shi Y; Sun E
    Cell Death Dis; 2020 Jul; 11(7):512. PubMed ID: 32641681
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Possible treatment and strategies for COVID-19: review and assessment.
    Trivedi N; Verma A; Kumar D
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12593-12608. PubMed ID: 33336780
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment options for COVID-19: The reality and challenges.
    Jean SS; Lee PI; Hsueh PR
    J Microbiol Immunol Infect; 2020 Jun; 53(3):436-443. PubMed ID: 32307245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential Drugs for the Treatment of COVID-19: Synthesis, Brief History and Application.
    Uddin E; Islam R; Ashrafuzzaman ; Bitu NA; Hossain MS; Islam AN; Asraf A; Hossen F; Mohapatra RK; Kudrat-E-Zahan M
    Curr Drug Res Rev; 2021; 13(3):184-202. PubMed ID: 34126913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COVID-19: morphology and mechanism of the SARS-CoV-2, global outbreak, medication, vaccines and future of the virus.
    Bhattacharyya P; Das S; Aich S; Sarkar J
    Front Biosci (Elite Ed); 2021 Dec; 13(2):272-290. PubMed ID: 34937314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action.
    Khan Z; Karataş Y; Rahman H
    Adv Ther; 2020 Jun; 37(6):2575-2579. PubMed ID: 32350686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug repurposing approach to fight COVID-19.
    Singh TU; Parida S; Lingaraju MC; Kesavan M; Kumar D; Singh RK
    Pharmacol Rep; 2020 Dec; 72(6):1479-1508. PubMed ID: 32889701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacotherapy in COVID-19; A narrative review for emergency providers.
    Mehta N; Mazer-Amirshahi M; Alkindi N; Pourmand A
    Am J Emerg Med; 2020 Jul; 38(7):1488-1493. PubMed ID: 32336586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A global treatments for coronaviruses including COVID-19.
    Yousefi B; Valizadeh S; Ghaffari H; Vahedi A; Karbalaei M; Eslami M
    J Cell Physiol; 2020 Dec; 235(12):9133-9142. PubMed ID: 32394467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiviral treatment of COVID-19.
    Şimşek Yavuz S; Ünal S
    Turk J Med Sci; 2020 Apr; 50(SI-1):611-619. PubMed ID: 32293834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Facts and Myths: Efficacies of Repurposing Chloroquine and Hydroxychloroquine for the Treatment of COVID-19.
    Al-Bari AA
    Curr Drug Targets; 2020; 21(16):1703-1721. PubMed ID: 32552642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
    Kumar P; Sah AK; Tripathi G; Kashyap A; Tripathi A; Rao R; Mishra PC; Mallick K; Husain A; Kashyap MK
    Mol Cell Biochem; 2021 Feb; 476(2):553-574. PubMed ID: 33029696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiviral therapy for coronavirus disease 2019.
    Gong S; Su J; Yan X; Li F; Hu L; Liu S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):598-602. PubMed ID: 32879113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic.
    Kheirabadi D; Haddad F; Mousavi-Roknabadi RS; Rezaeisadrabadi M; Dehghan H; Fazlzadeh A
    J Med Virol; 2021 May; 93(5):2705-2721. PubMed ID: 33463727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2.
    Siddiqui AJ; Jahan S; Ashraf SA; Alreshidi M; Ashraf MS; Patel M; Snoussi M; Singh R; Adnan M
    J Biomol Struct Dyn; 2021 Oct; 39(17):6828-6841. PubMed ID: 32752944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19).
    Lovato ECW; Barboza LN; Wietzikoski S; de Souza ANV; Auth PA; Junior AG; Dos Reis Lívero FA
    Curr Pharm Des; 2021; 27(1):115-126. PubMed ID: 32634080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century.
    Sanghai N; Shafiq K; Tranmer GK
    Mini Rev Med Chem; 2021; 21(1):3-9. PubMed ID: 32838716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
    Quiros Roldan E; Biasiotto G; Magro P; Zanella I
    Pharmacol Res; 2020 Aug; 158():104904. PubMed ID: 32430286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.